Rapid onset of bronchodilation with formoterol/beclomethasone Modulite and formoterol/budesonide Turbuhaler as compared to formoterol alone in patients with COPD

被引：6
|
作者：
Cazzola, Mario [1 ]
Pasqua, Franco [2 ]
Ferri, Luigi [3 ]
Biscione, Gianluca [2 ]
Cardaci, Vittorio [3 ]
Matera, Maria Gabriella [4 ]
机构：
[1] Univ Roma Tor Vergata, Dept Internal Med, Unit Resp Clin Pharmacol, I-00133 Rome, Italy
[2] Hosp San Raffaele, Velletri, Rome, Italy
[3] IRCCS San Raffaele Pisana, Rehabilitat Pneumol, Rome, Italy
[4] Univ Naples 2, Dept Expt Med, Pharmacol Unit, Naples, Italy
来源：
PULMONARY PHARMACOLOGY & THERAPEUTICS | 2011年 / 24卷 / 01期
关键词：
Formoterol; Beclomethasone; Budesonide; COPD; Onset of action; BLOOD MONONUCLEAR-CELLS; ALLERGEN CHALLENGE; SMOOTH-MUSCLE; GLUCOCORTICOIDS; MECHANISMS; RECEPTORS; ASTHMA; LUNG; CORTICOSTEROIDS; TRANSCRIPTION;
D O I：
10.1016/j.pupt.2010.08.005
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
In the present study, we examined whether there is a difference in the onset of bronchodilatation between formoterol/beclomethasone 12/200 mu g Modulite and formoterol/budesonide 9/320 mu g Turbuhaler in patients with COPD. We enrolled 28 patients with stable COPD. Both formoterol/beclomethasone and formoterol/budesonide elicited a larger mean FEV1-AUC(0-15min) than formoterol alone, whereas there was no significant difference between their FEV1-AUC(0-15min). Also the change in FEV1 15 min after inhalation of formoterol/beclomethasone combination or formoterol/budesonide combination was greater than that induced by formoterol alone. This study confirms the rapid effect of the inhaled corticosteroid component when combined with formoterol and indicates that the onset of bronchodilation of formoterol/beclomethasone Modulite and formoterol/budesonide Turbuhaler are similar and greater than formoterol alone in patients with COPD. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码：118 / 122
页数：5
相关论文
共 50 条
  • [21] Bronchodilation with formoterol (Oxis®) Turbuhaler® therapy in patients previously unresponsive to salmeterol Diskus®
    Bartuschka, B
    Querfurt, H
    Ortland, C
    Petermann, W
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 107 (02) : S110 - S110
  • [22] Improved asthma control with budesonide/formoterol in a single inhaler, compared with budesonide alone
    Zetterström, O
    Buhl, R
    Mellem, H
    Perpiñá, M
    Hedman, J
    O'Neill, S
    Ekström, T
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2001, 18 (02) : 262 - 268
  • [23] Onset of action of single doses of formoterol administered via turbuhaler in patients with stable COPD
    Cazzola, M
    Centanni, S
    Regorda, C
    di Marco, F
    di Perna, F
    Carlucci, P
    Boveri, B
    Santus, P
    [J]. PULMONARY PHARMACOLOGY & THERAPEUTICS, 2001, 14 (01) : 41 - 45
  • [24] Efficacy and safety of high-dose budesonide/formoterol (Symbicort®) compared with budesonide administered either concomitantly with formoterol or alone in patients with persistent symptomatic asthma
    Jenkins, C
    Kolarikova, R
    Kuna, P
    Caillaud, D
    Sanchis, J
    Popp, W
    Pettersson, E
    [J]. RESPIROLOGY, 2006, 11 (03) : 276 - 286
  • [25] Budesonide/formoterol improves lung function compared with budesonide alone in children with asthma
    Pohunek, Petr
    Kuna, Piotr
    Jorup, Carin
    De Boeck, Kris
    [J]. PEDIATRIC ALLERGY AND IMMUNOLOGY, 2006, 17 (06) : 458 - 465
  • [26] Formoterol turbuhaler® 4.5 μg (delivered dose) has a rapid onset and 12-h duration of bronchodilation
    Selroos, O
    Ekström, T
    [J]. PULMONARY PHARMACOLOGY & THERAPEUTICS, 2002, 15 (02) : 175 - 183
  • [27] Extrafine Beclomethasone/formoterol compared to Fluticasone/salmeterol Combination Therapy in COPD
    Dave Singh
    Gabriele Nicolini
    Eddi Bindi
    Massimo Corradi
    Daniele Guastalla
    Jorg Kampschulte
    Władysław Pierzchała
    Abdullah Sayiner
    Mária Szilasi
    Claudio Terzano
    Jørgen Vestbo
    [J]. BMC Pulmonary Medicine, 14
  • [28] Cost effectiveness of budesonide/formoterol in a single inhaler for COPD compared with each monocomponent used alone
    Löfdahl, CG
    Ericsson, Å
    Svensson, K
    Andreasson, E
    [J]. PHARMACOECONOMICS, 2005, 23 (04) : 365 - 375
  • [29] Cost effectiveness of budesonide/formoterol in a single inhaler for COPD compared with each monocomponent used alone
    Löfdahl C.-G.
    Ericsson Å.
    Svensson K.
    Andreasson E.
    [J]. PharmacoEconomics, 2005, 23 (4) : 365 - 375
  • [30] Extrafine Beclomethasone/formoterol compared to Fluticasone/salmeterol Combination Therapy in COPD
    Singh, Dave
    Nicolini, Gabriele
    Bindi, Eddi
    Corradi, Massimo
    Guastalla, Daniele
    Kampschulte, Jorg
    Pierzchala, Wladyslaw
    Sayiner, Abdullah
    Szilasi, Maria
    Terzano, Claudio
    Vestbo, Jorgen
    [J]. BMC PULMONARY MEDICINE, 2014, 14
12345